1. Home
  2. POWI vs KNSA Comparison

POWI vs KNSA Comparison

Compare POWI & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWI
  • KNSA
  • Stock Information
  • Founded
  • POWI 1988
  • KNSA 2015
  • Country
  • POWI United States
  • KNSA United Kingdom
  • Employees
  • POWI N/A
  • KNSA N/A
  • Industry
  • POWI Semiconductors
  • KNSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • POWI Technology
  • KNSA Health Care
  • Exchange
  • POWI Nasdaq
  • KNSA Nasdaq
  • Market Cap
  • POWI 2.3B
  • KNSA 2.6B
  • IPO Year
  • POWI 1997
  • KNSA 2018
  • Fundamental
  • Price
  • POWI $37.67
  • KNSA $38.30
  • Analyst Decision
  • POWI Strong Buy
  • KNSA Strong Buy
  • Analyst Count
  • POWI 3
  • KNSA 7
  • Target Price
  • POWI $61.67
  • KNSA $44.00
  • AVG Volume (30 Days)
  • POWI 698.6K
  • KNSA 403.5K
  • Earning Date
  • POWI 11-05-2025
  • KNSA 10-28-2025
  • Dividend Yield
  • POWI 2.23%
  • KNSA N/A
  • EPS Growth
  • POWI N/A
  • KNSA N/A
  • EPS
  • POWI 0.59
  • KNSA 0.07
  • Revenue
  • POWI $442,468,000.00
  • KNSA $529,332,000.00
  • Revenue This Year
  • POWI $11.06
  • KNSA $37.21
  • Revenue Next Year
  • POWI $14.36
  • KNSA $12.07
  • P/E Ratio
  • POWI $63.85
  • KNSA $577.26
  • Revenue Growth
  • POWI 7.16
  • KNSA 56.18
  • 52 Week Low
  • POWI $37.62
  • KNSA $17.82
  • 52 Week High
  • POWI $69.53
  • KNSA $39.12
  • Technical
  • Relative Strength Index (RSI)
  • POWI 29.03
  • KNSA 63.72
  • Support Level
  • POWI $38.59
  • KNSA $37.35
  • Resistance Level
  • POWI $39.78
  • KNSA $38.83
  • Average True Range (ATR)
  • POWI 1.34
  • KNSA 0.97
  • MACD
  • POWI -0.17
  • KNSA 0.03
  • Stochastic Oscillator
  • POWI 0.65
  • KNSA 76.50

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: